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Abstract:  Public health interventions have received increased attention from policy 
makers, and there has been a corresponding increase in the number of economic 
evaluations within the domain of public health. However, methods to evaluate public 
health interventions are less well established than those for medical interventions. Focusing 
on health as an outcome measure is likely to underestimate the impact of many public 
health interventions. This paper provides a review of outcome measures in public health; 
and describes the benefits of using the capability approach as a means to developing an all 
encompassing outcome measure. 
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1. Introduction  
Public health interventions are intended to promote health or prevent ill health in communities or 
populations, and can be distinguished from clinical or medical interventions which intend to prevent or 
treat ill health in individuals [1]. The nature of public health interventions and programmes has 
evolved considerably over time. This evolution has been summarized by Eriksson as four generations 
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or paradigms [2]: single factor interventions have given way to multifactorial interventions which then 
became community based, and now we have nearly come full circle with a returned focus on policy 
and environmental actions; from the ‘old public health’ to the ‘new public health’ [2,3]. As a 
consequence interventions are becoming more complex [4], where the complexity lies in the 
intervention, the outcomes and the evaluation itself. 
Limited budgets and competing demands have resulted in a growing need for economic evidence to 
guide decision making regarding the funding of both health (medical) technologies and public health 
programmes. A review of the literature from 1966 to 2005 has documented the growth in economic 
evaluations of public health interventions; only 12% of nearly 1,700 papers pre-dated 1999 [5]. The 
review found that the majority of papers were concerned with evaluating the prevention of 
communicable diseases (60%), or the evaluation of screening or diagnostic tools for cancer (35%); and 
78% of all papers undertook cost effectiveness analyses (CEA) or cost consequence analyses (CCA) 
(see Simoens [6] in this special issue for a health economics primer which reviews the different types 
of economic evaluation approaches). The importance of evaluating public health programmes has been 
noted at a policy level in the UK. The Wanless Reports [7,8] suggested that an efficient approach to 
improving the health of the population and reducing health inequalities includes the generation of 
evidence on the cost-effectiveness of public health strategies. As a result of these recommendations the 
National Institute for Clinical Excellence (NICE) subsumed the role of the Health Development 
Agency (HDA) and now the National Institute for Health and Clinical Excellence (NICE) is tasked 
with providing guidance on the effectiveness and cost effectiveness of public health interventions in 
the UK.  
While Wanless argued that the “[e]conomic evaluation of public health interventions is not 
inherently different from the evaluation of other health interventions. Standard principles are the   
same” [8, p. 146], there are in fact a wealth of complexities in the application of the methodology that 
need to be addressed before economic evaluations of public health interventions are able to produce 
quality evidence to inform rationing decisions; especially when the decision makers are comparing 
different types of public health programmes, and comparing public health interventions with other 
health care interventions. This paper initially reviews the methodological challenges that have been 
previously identified [9,10], and then specifically focuses on the issue of the measurement of 
outcomes. A methodological discussion of outcome measurement is presented, which includes a 
selective review of a number of recently published economic evaluations of public health 
interventions. The paper then focuses on operationalising Sen’s [11,12] capability approach as a means 
of measuring benefit, before concluding with a discussion of a number of the outstanding issues, and 
avenues for future research. 
2. Methodological Issues in the Economic Evaluation of Public Health Interventions 
The problems of applying economic evaluation to public health interventions were first outlined in 
an HDA briefing paper [13]. This highlighted the need for a common framework for consistent and 
transparent decision making, which was flexible enough to capture the multi-dimensional, complex 
and layered outcomes of public health policies and interventions. These issues and others were further 
explored in a paper co-authored by members of NICE, the so-called decision-makers [9]. They detailed Int. J. Environ. Res. Public Health 2010, 7          
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the challenges of producing public health guidance under NICE’s expanded remit. Seven issues were 
identified which were labeled as research priorities. These include: 
 
  Measuring benefit, the use of quality adjusted life years (QALYs) (and EQ-5D) and the possible 
need for evaluations to have more than one outcome measure; 
  Public versus individual, the role of individual choice in population based interventions, and how 
to account for any resulting externalities; 
  Equity versus efficiency, public health programmes frequently target health inequalities, such that 
the issue of weighting outcomes may need to be addressed together with other   
distributional concerns; 
  Perspective, in the NICE Reference Case [14] the perspective for public health evaluations has 
been broadened to include the public sector, this may lead to inconsistencies when making 
comparisons with clinical interventions; 
  Extrapolation, what is the appropriate time horizon and how meaningful will such extrapolations 
be in the absence of robust evidence; 
  Quality of evidence, the evidence base is weaker in public health, and controlled trials are   
often impossible; 
  Cost effectiveness threshold, should the same threshold be applied to both clinical and public 
health interventions. 
 
A more rigorous assessment of the issues of applying standard economic analysis techniques to 
public health evaluations has also been undertaken [10]. Weatherly and colleagues considered existing 
reviews of the literature, which included the Wanless Reports [7,8], and identified what they regard to 
be the main methodological challenges facing health economists in this area. These include: 
 
  Attribution of outcomes, how best to obtain true estimates of effect, what can the existing 
literature offer by way of evidence, how can primary research generate quality evidence, and 
what is the appropriate time frame within which to measure success; 
  Measuring and valuing outcomes, what can be measured versus what should be measured, the 
need for a more generic measure of wellbeing, and sector-specific generic measures of outcome, 
as well as greater consideration for alternative evaluation approaches;  
  Intersectoral costs and consequences, quantifying the intersectoral impacts of public health 
interventions, assessment of a general equilibrium approach to the evaluation of public   
health interventions; 
  Equity considerations, a need for heath inequality impact assessment and research on   
equity weighting. 
 
Given these four areas they then undertook a review of the empirical literature in eleven public 
health domains (accidents, alcohol, ante natal and post natal visiting, drug use, HIV/AIDS, low birth 
weight, obesity and physical activity, sexually transmitted infections, smoking, teenage pregnancy and 
youth suicide prevention) and concluded that the published literature offers few insights and there is 
little in the way of best practice, suggesting more methodological research is required. Int. J. Environ. Res. Public Health 2010, 7          
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In the rest of this paper we wish to focus on a single issue identified by both Chalkidou et al. [9] 
and Weatherly et al. [10] that of the measurement (and valuation) of benefits (outcomes). A number of 
the other issues have already been addressed in the literature, including work on systematic review 
methods [15], the implications of alternative perspectives [16,17], and the incorporation of equity 
considerations [18], as well as more general guidance on how to evaluate complex   
interventions [19,20]. 
3. Outcome Measurement in Economic Evaluation 
Economists are often merely seen as experts on costing, but outcome measurement is a key issue in 
economic evaluation [21]. Outcome measures used in economic evaluations can generally be 
categorized as one of the following: 
 
  Condition specific, for example episode free days, which would have different meanings for say 
asthma [22] and gastroesphageal reflux disease [23]; 
  Morbidity, clinical measures of, say, prevalence or events [24], generally expressed in   
natural units; 
  Generic health or quality of life, such as the SF-36 [25] or Sickness Impact Profile [26]; 
  Mortality, so to estimate life years gained; 
  Preference based, either generic like the EQ-5D [27] or SF-6D [28] or condition   
specific [29,30], which allow for the estimation of QALYs; 
  Monetary, as measured in a contingent valuation exercise to elicit an individual’s   
willingness-to-pay for an intervention [31]. 
 
The choice of outcome measure is very dependent on the research question being addressed (which 
includes the perspective employed) and the type of economic evaluation that is being undertaken. A 
CEA, where outcomes are expressed in natural units, remains a relatively common approach within 
health technology assessment, and this is also true for public health interventions. McDaid and   
Needle [5] found in their review that 57% of all published evaluations were CEAs, while   
Weatherly et al. [10] found in their more selective review that 36% of studies were CEAs. Some 
examples of published CEAs of public health interventions include evaluations of: targeted screening 
for cardiovascular disease which estimate the cost per case [32]; vaccination programmes which 
estimate the cost per hospitalization avoided [33]; surgical interventions for obesity which estimate the 
cost per pound lost [34]; and behavioral interventions for smoking cessation which estimate the cost 
per quitter [35]. An example of a more complex public health intervention is the recently published 
evaluation of an intervention for vulnerable families [36]. Here the authors estimated the cost per 
improvement in maternal sensitivity and cost per improvement in infant cooperativeness (components 
of the CARE Index). 
While CEA are commonplace they are limited in that they can only inform decisions within 
individual disease or intervention areas. In order to facilitate comparisons across a range of topics, 
diseases and interventions, including both life saving and life enhancing interventions, a common 
generic outcome measure which incorporates the effects of both quality and quantity of life was Int. J. Environ. Res. Public Health 2010, 7          
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developed. A QALY combines both mortality and morbidity measures of health by weighting a year of 
life by the quality of life (that is utility) experienced [37]. This quality adjustment explicitly involves 
an expression of preference which can be elicited by employing a range of preference elicitation 
techniques (like time-trade off or standard gamble [38]), but generally off the shelf instruments are 
used like the EQ-5D (a five dimension questionnaire) [27], or the more recent utility values extracted 
from the SF-36, using the SF-6D [39]. Once estimated QALYs are compared to costs in the form of an 
incremental cost effectiveness ratio (ICER) and comparisons across interventions and disease areas can 
be made using cost per QALY gained, thereby informing decisions as to whether an intervention can 
be considered value-for-money. 
Some examples of published cost utility analyses (CUAs) of public health interventions include 
those that estimate the cost per QALY gained for diabetes screening [40], vaccination   
programmes [41], surgical interventions for obesity [42], and smoking cessation [35]. There are also 
CUAs that employ disability adjusted life years (DALYs) as an outcome measure, thereby estimating 
the cost per DALY saved [43], averted [44] or recovered [45]. 
QALYs (and suggested alternatives, such as the healthy year equivalent (HYEs) [46] and the saved 
young life equivalent (SAVE) [47]) are, however, not without their critics. As discussed above, one of 
the limitations is that they focus on health outcomes [48,49], and there is now a need to evaluate 
interventions that seek to improve an individual’s quality of life beyond health. Many public health 
interventions seek to impact on broader aspects of quality of life, not just health, but also non-health 
outcomes such as empowerment, participation and crime. Therefore, QALYs and their associated 
quality of life measures like the EQ-5D or SF-6D are likely to underestimate the relative benefits of 
public health interventions when compared to health care interventions. 
An alternative approach to valuing outcomes, which can potentially overcome this bias, and capture 
all benefits (both health and non-health) of interest is the contingent valuation method. Contingent 
valuation (CV) is a means by which outcomes are valued in monetary terms. The most common 
approach to eliciting monetary valuations is to use the willingness-to-pay (WTP) approach [31]. In its 
simplest form, individuals are asked how much they would be willing to pay to obtain the benefit of an 
intervention. If this monetary valuation is greater than the cost of providing the intervention, then a 
cost-benefit analysis (CBA) would suggest that the intervention is worthwhile. There are a number of 
practical and methodological problems with the CV approach [50], in particular there is a strong 
relationship between income and WTP, whereby those on low income provide low valuations. In the 
context of evaluating public health intervention this could be problematic, as many interventions are 
targeted at deprived individuals, such that the use of WTP could undervalue the true benefit. While, 
Kelly et al. [13] conclude that, at a societal level, CBA is the ideal method, as it permits tradeoffs 
across different sectors of the economy, they admit that there are problems with this approach, and 
they go on to suggest that within a pragmatic framework cost-consequence analysis (CCA) may be 
able to capture the layered outcomes of public health interventions. Note that few real world examples 
of CBA exist, indeed of the four studies that were initially identified as CBA in the review by 
Weatherley et al. [10] three were subsequently deemed to be CCAs and one was a CUA; although they 
did identify one study which elicited WTP values for a water fluoridation programme, but it did not 
estimate the costs of the programme [51]. 
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A CCA [52], unlike the approaches described above, does not explicitly compare the costs of an 
intervention with its outcomes (thus is not an economic evaluation in the strict sense). Multiple 
outcomes are presented, often in a tabulated approach with costs, and while it cannot be used to rank 
interventions, it has been heralded as a better way to present (often confusing) economic information 
to decision makers [53]. CCA has been used previously to evaluate complex interventions where 
outcomes cannot easily be summarized in a single measure (see Byford and Sefton [54] for   
some examples). 
Sen’s capability approach [11,12] could provide a possible solution to the limitations discussed 
above, in that it expands the evaluation space to consider whether a programme enhances an 
individual’s capability. While there is much (theoretical) discussion of the application of the 
‘capability approach’ within the health economics (including economic evaluation) literature, there are 
few applications of the approach. We first review the approach as put forward by Sen and his 
supporters, before providing a discussion of the theoretical literature within the health 
economics/economic evaluation domain. We then provide a short discussion of the applied approaches 
to measuring so-called capability sets.  
4. The Capability Approach 
The capability approach, as put forward by Sen [11,12], suggests that wellbeing should be measured 
not according to what individuals actually do (functionings) but what they can do (capabilities).  
“Functionings represent parts of the state of a person—in particular the various things that he or she 
manages to do or be in leading a life. The capability of a person reflects the alternative combinations 
of functionings the person can achieve, and from which he or she can choose one collection. The 
approach is based on a view of living as a combination of various ‘doings and beings’, with quality of 
life to be assessed in terms of the capability to achieve valuable functionings.” [12, p. 31] 
Comim neatly described the approach as “a framework for evaluating and assessing social 
arrangements, standards of living, inequality, poverty, justice, quality of life or wellbeing” [55, p. 162]. 
Of importance is the evaluation space; it diverges from narrow utility space, which is concerned with 
the pleasure obtained from the consumption on goods and services, and instead encapsulates an 
informational space, where evaluative judgments occur according to an individual’s freedom. 
Therefore, Sen’s approach is based on value judgments, which ultimately relate to an individual’s 
capability set, and in this sense it can be described as ‘extra-welfarist’ [56-58]. 
The capability framework for evaluation is based on two distinctions, that between a person’s 
agency goals and their own wellbeing (where agency goals refer to the notion that individuals may 
have objectives which relate to the well-being of others and to commitments entirely outside 
themselves [59]), and that between achievement (functioning) and the freedom to achieve 
(capabilities). Arguably one of the limitations of the approach is that “Sen has not specified how the 
various value judgments that inhere in his approach and are required in order for its practical use 
(whether at the micro or macro level) are to be made” [60, p. 3], as he believes that value selection and 
discrimination are an intrinsic part of the approach. Nussbaum [61], however, has identified what she 
regards as central human capabilities, and provides a list of ten capabilities: life; bodily health; bodily 
integrity; senses, imagination and thought; emotions; practical reason; affiliation; other species; play; Int. J. Environ. Res. Public Health 2010, 7          
 
 
2280
and control over one’s environment. Other prescriptive lists also exist, which have varying degrees of 
abstraction and generalization [62]. The existence of such lists are crucial in the evaluation of 
capability sets (that is the identification of freedoms) and the subsequent operationalisation of the 
approach (that is evaluating whether such freedoms are achievable).  
4.1. The Application of the Approach to Health Economics—Theoretical Literature 
The first insight to the significance that the capability approach might have within the health 
economics domain became apparent when Culyer [56] used Sen’s theory to develop his own   
extra-welfarist perspective to economic evaluation (which provided some justification for using 
QALYs). This perspective, as discussed above, is limited in that it focuses on health, while Sen’s 
capability approach is much broader. Furthermore, Culyer’s approach is largely concerned with 
functionings (the achievement of health states) compared with Sen’s ideas on the ability   
to function [63]. 
Anand has advanced the approach, first discussing the application of the approach to health care 
rationing and resource allocation [64,65] (including editing a special issue in Social Science and 
Medicine [66]) and more recently by attempting to operationalise the approach [67,68]. However, it 
was Cookson [69] who first explored the possibility of applying the approach to outcome measurement 
within economic evaluation. He suggests that there are three ways it could be used: 
 
(a) direct estimation and valuation of capability sets; 
(b) ‘merging’ preference-based measurements, such as willingness to pay, with capabilities; 
(c) re-interpreting the QALY approach. 
 
Cookson dismisses the first approach as unfeasible at present, arguing that there is no agreed list of 
functionings, and that any movement from functionings to capabilities is problematic due to different 
preferences. While the second approach is also dismissed due to “the adaptive and constructed nature 
of individual preferences over time and under uncertainty” [69, p. 818]. Subsequently, Cookson 
proposes re-interpreting QALY data generated from a standardised instrument so that the   
re-interpreted data (the ‘capability QALY’, note others refer to this all encompassing concept as the 
‘super QALY’) represents the value of an individual’s capability set. He argues that responses to 
questions in generic health state valuation instruments can be taken to reflect the value of an 
unspecified capability set, because health affects an individual’s freedom to choose   
non-health activities. 
Anand [70] disputes Cookson’s conjecture that capability measurement is not yet feasible. In 
particular he claims while early attempts to measure capability concluded that it was immeasurable, it 
is now much more feasible to measure capability (indeed the UN’s Human Development Index has it’s 
foundations within the capability approach). Anand identifies Nussbaum’s list of ten domains as a 
good starting point, and then shows that many of these are well represented by questions in the British 
Household Panel Survey (BHPS), a large longitudinal survey extensively used by economists and 
social scientists alike [67,68].  Int. J. Environ. Res. Public Health 2010, 7          
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Recently Coast et al. [63,71] have sought to reignite the debate surrounding the application of the 
capability approach within health economics. Whilst tracing the origins and impacts of extra-welfarism 
on health care policy, they discuss a number of the issues surrounding further integration and 
application of the approach for use in economic evaluation. They highlight the issue identified above, 
that the capability approach has a wider evaluative space, but also focus on the fact that extra-welfarist 
approaches seek to maximize health, whereas the capability approach is more concerned with issues of 
equity, distribution, and the equality of basic capabilities [72]. Thus, while we are presenting the 
capability approach as a means to overcoming the problems associated with measuring outcomes for 
public health, the approach could also provide a solution to addressing a number of the equity issues 
that have been raised [9,10].  
4.2. The Application of the Approach to (Health) Economics—Empirical Literature 
The literature on capabilities, whilst extensive, remains largely conceptual. Robeyns in a review of 
the literature in 2000 noted that “despite the fact that Sen published Commodities and Capabilities in 
1985, the number of empirical applications is still quite limited” [73, p. 26] (see Kyklys and   
Robeyns [74] and Comim et al. [75] for more up-to-date reviews). Despite this there have been some 
empirical applications, the majority of which relate to poverty, development, social justice or gender 
inequality (see [74,76]), although there are a (growing) number in the health economics field. 
As discussed above, Anand has sought to operationalise the approach by assessing capabilities 
using secondary data. He (and colleagues) exploited data from the BHPS and estimated the 
relationship between wellbeing and capability [67]. They concluded that secondary data sources can 
provide some information on capability. The incompleteness led them to consider other data sources 
and they subsequently developed further indicators, which are aligned within Nussbaum’s list of ten 
capabilities [61]. These indicators were included in an internet survey, along with measures of 
wellbeing, and the indicators of capability were found to perform well in terms of being strong 
predictors of wellbeing [68]. The drawback of their approach, however, in terms of outcome 
measurement for economic evaluation is that there are over 60 indicators of capability, making its 
usability limited. 
Further research sought to reduce and refine Anand’s survey, so to provide a summary measure of 
capability which could be used when evaluating complex public health intervention [77]. The 
reduction and refinement of the questionnaire took place across a number of stages, using both 
qualitative (focus group discussions and in-depth interviews) and quantitative (secondary data analysis 
and primary data collection using postal surveys) approaches [78]. The final stage tested the validity of 
the questionnaire. The questionnaire was reduced from its original 65 questions to 18 specific 
capability items, which remain aligned with Nussbaum’s list of central human capabilities. The 
finalised questionnaire, and a weighted index of capability (whereby each item was given the same 
weight), was found to be responsive to different groups of individuals (as categorised by age, gender 
and deprivation), and measure something additional to health and wellbeing (as measured by the   
EQ-5D and a global QoL scale, respectively), although was still highly correlated with these measures. 
This research shows the potential to operationalise the capability approach, despite Cookson’s 
reservations [69]. However, one drawback was that a preference based index was not developed (that Int. J. Environ. Res. Public Health 2010, 7          
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is one that represents trade-offs and choices across the capability set), as it was deemed beyond the 
scope of the project; this is however wholly possible, and other researchers have successfully 
developed a preference based index.  
Coast and colleagues have developed an index of capability specifically for use in the   
elderly [79-81]. While eliciting attributes for a generic quality of life measure for older people (by 
interpreting in-depth qualitative interviews), a similarity became apparent between the resulting 
attributes (attachment, role, enjoyment, security and control) and Sen’s capability approach. The 
attributes were valued using best-worst scaling within a discrete choice framework [82]; and were 
combined to form an index, whereby 0 represents a state of no capability and 1 is a state of full 
capability. Their approach has many merits, especially their choice of valuation technique, but it is 
limited in its generalisability beyond the elderly. The research team has since been funded to undertake 
a similar exercise with a broader scope, and they are now seeking to measure capabilities in the general 
adult population [83]. 
Other health economists have used the approach to assess the quality of life of sufferers of chronic 
pain [84]. This project used a multi-attribute value method [85] to scale the levels within functionings 
and quantify trade-offs between capabilities [86]. Within the broader area of health (but not 
specifically health economics), there have been a number of papers which have also attempted to 
estimate capability. In particular, disability appears to readily lend itself to the capability   
approach [87], and there have been attempts to estimate the additional income needed by a disabled 
person to reach the wellbeing of a non-disabled person [88,89].  
4.3. Outstanding Issues With Regard to Operationalising the Approach for Use in Economic 
Evaluations 
A fundamental issue with operationalising the capability approach for use in economic evaluations 
is the need to develop a preference based measure, such that it reflects the relative value placed on the 
various dimensions and components of capability. However, the method by which values should be 
elicited remains unclear [80]. Cookson [69] dismissed the valuation of capability sets as unfeasible, 
citing Sen [11,90] who rejects the use of either choices or desires to value capabilities, and instead 
suggested that perhaps views on value judgements be elicited instead. Coast and colleagues [80] argue 
that their best-worst scaling approach, because respondents are asked to only specify the attribute 
levels which they think are the best and worst, elicits ‘values’ (as Cookson suggests) rather than 
‘choices’, because the elicitation exercise does not ask individuals to risk or sacrifice, as would be the 
case in a standard gamble or time trade-off exercise, respectively. 
There has been some research comparing cardinal valuation methods which elicit the degree of 
preference (as is the case with standard gamble, time tradeoff and visual analogue scale methods) to 
ordinal methods which elicit information on the ordering of preference using conventional Discrete 
Choice Experiment (DCE) models [91] and best-worst scaling approaches [92]. DCEs were found to 
have a number of practical advantages, including the fact that less abstract reasoning is required on the 
part of the respondents (compared to time tradeoff and standard gamble exercises); but due to their 
ordinal nature the elicited values require rescaling, that is they need to be anchored. To produce a 
measure which can be used to weight length of life (as is the case with QALYs) [93] and allow for Int. J. Environ. Res. Public Health 2010, 7          
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interpersonal comparisons [94], it is necessary that the scale is anchored at zero which is dead, with 
full health being one. While Ratcliffe and colleagues [91] show that it is possible to undertake such 
rescaling using rank and DCE data for a condition-specific health measure, within the context of the 
capability approach there is a further unresolved issue. Although it is generally accepted that the 
absence of health is the same as the absence of life (that is it is appropriate that dead be given a value 
of zero), there has been little debate about whether the absence of capability is the same as the absence 
of life; but if a capability index is to be used in a similar manner to a QALY such a discussion is 
required. Notably, Coast et al. [80] take a philosophical approach where the absence of capability is 
given a value of zero, thereby avoiding the need to value death. 
Adaptation, where individuals may not recognise their own lack of wellbeing because they have 
adapted to their situation, is also an issue when undertaking a preference based valuation. This is 
despite the fact that Sen used the issue of adaptation as the basis for, rejecting utilitarian approaches 
which seek to value wellbeing and, replacing utility with an informational space based on   
functionings [90]. Adaptation is an issue when using the public to value hypothetical health states as 
the valuation often reflects the initial shock response, rather than the long term (patient) experience; 
this means that the general public often give lower values compared to patients who may have   
adapted [95]. The measurement of preferences for different capability states could also suffer from 
similar adaptation issues (with the additional issue of functioning in one domain potentially over 
compensating for a lack of capability in another). Burchardt [59] has shown that agency goals are 
adaptive, and that an assessment of inequality based on agency goals may be bias because of lower 
aspirations (when setting goals), and therefore greater success in achieving goals. One solution to 
adaptation that Sen has advocated is using an expert-centred approach; such that in the public health 
context, public health professionals or policy makers would be used to provide values for different 
capability states [71]. This is entirely plausible but conflicts with the current movement towards patient 
and public involvement in decision making.  
5. Conclusion 
The need to undertake economic evaluations across a wider range of interventions, which 
encompass both health and non-health outcomes, requires an alternative to the conventional cost per 
QALY gained approach. Sen’s capability approach, although theoretically challenging, could provide a 
possible solution. 
The benefits of using the capability approach are numerous. It offers a much richer set of 
dimensions for evaluation, which given the nature of public health and social interventions, with their 
many and complex outcomes, makes the approach ideal for capturing all these outcomes, rather than 
focusing solely on health status. The equitable underpinnings of the approach are also appropriate for 
use with public health interventions which often involve reducing inequalities across groups (namely 
improving deprivation) as an overriding aim. 
To operationalise the approach for use in economic evaluations, it is necessary to generate an index 
whereby an individual’s capability (or capability set) is described by a single composite number. This 
involves a number of challenges. Key among these is the need to identify a legitimate capability space 
and then to accurately measure relative preferences for each capability. Indices, and preference Int. J. Environ. Res. Public Health 2010, 7          
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measurement more generally, raise the issues of which valuation technique to use, whether and how to 
anchor the index, and how to control for adaptation. 
Future research will contribute to the removal of many of the conceptual challenges; however, in 
the long run a potential institutional barrier to the adoption of a capability approach is that the   
QALY-based extra-welfarist approach is now the norm in health economics. For instance, within the 
UK NICE has a clear recommendation that QALYs should be used as the reference case, and research 
on methods for cost effectiveness analysis (as opposed to outcomes research) continues to grow. 
Although there are a number of alternative approaches (experienced utility [96] and happiness/life 
satisfaction/wellbeing [97,98]) which provide possible competition if support for the extra-welfarist 
approach was to waiver, the capability approach would appear to have strength as a means of 
measuring the effectiveness (and thus cost effectiveness) of public health interventions. 
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